CD38: From Positive to Negative Expression after Daratumumab Treatment

CD38 is a glycoprotein expressed at a low level in myeloid and lymphoid tissues. However, it is highly and homogeneously expressed in plasma cells (PC) in multiple myeloma. Daratumumab is a human CD38-specific IgG1 antibody available for the treatment of multiple myeloma in Colombia. It has been aut...

Descripción completa

Detalles Bibliográficos
Autores principales: Patiño-Escobar, Bonell, Ramos, Roberto, Linares, Maximo, Mejía, Angie, Alcalá, Sebastián
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213648/
https://www.ncbi.nlm.nih.gov/pubmed/32399359
http://dx.doi.org/10.7759/cureus.7627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213648/
https://www.ncbi.nlm.nih.gov/pubmed/32399359
http://dx.doi.org/10.7759/cureus.7627

Ejemplares similares